Royce & Associates LP Gilead Sciences, Inc. Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

A detailed history of Royce & Associates LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 80,000 shares of GILD stock, worth $7.19 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

80,000

Previous 80,000 -0.0%

Holding current value

$7.19 Million

Previous $5.49 Million 22.18%

% of portfolio

0.06%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $1.2 Million - $1.38 Million	19,000 Added 31.15%	80,000 $5.49 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $214,740 - $261,870	3,000 Added 5.17%	61,000 $4.47 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $332,730 - $363,015	4,500 Added 8.41%	58,000 $4.35 Million
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $1.1 Million - $1.26 Million	14,500 Added 37.18%	53,500 $4.12 Million
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $927,720 - $1.06 Million	12,000 Added 44.44%	39,000 $3.24 Million
Q4 2022 May 23, 2023	SELL	$62.32 - $89.47 $747,840 - $1.07 Million	-12,000 Reduced 30.77%	27,000 $2.32 Million
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $288,600 - $325,050	5,000 Added 22.73%	27,000 $1.67 Million
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $1.27 Million - $1.6 Million	22,000 New	22,000 $1.31 Million
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $3.54 Million - $4.01 Million	-54,500 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $101,535 - $109,545	-1,500 Reduced 2.68%	54,500 $3.81 Million
Q2 2021 Aug 06, 2021	BUY	$63.47 - $69.35 $31,735 - $34,675	500 Added 0.9%	56,000 $3.86 Million
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $2.13 Million - $2.43 Million	35,500 Added 177.5%	55,500 $3.59 Million
Q4 2020 Feb 08, 2021	BUY	$56.65 - $64.55 $1.13 Million - $1.29 Million	20,000 New	20,000 $1.17 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Gilead Sciences, Inc. Transaction History